Skip to content

Medpace

NASDAQ: MEDP · USD

Medpace cash flow and EPS—

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$318.675M
Medpace capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2016 Q31.01% · $2.15MUnavailable0% · $0MUnavailable98.99% · $210.018M100% · $212.168M
FY 2016 Q43.34% · $5.694MUnavailable0% · $0MUnavailable96.66% · $165.006M100% · $170.7M
FY 2017 Q158.57% · $4.374MUnavailableUnavailableUnavailable41.43% · $3.094M100% · $7.468M
FY 2017 Q25.28% · $1.645MUnavailable84.78% · $26.4MUnavailable9.93% · $3.093M100% · $31.138M
FY 2017 Q33.11% · $2.31MUnavailable92.72% · $68.855MUnavailable4.17% · $3.094M100% · $74.259M
FY 2017 Q45.08% · $3.395MUnavailable90.29% · $60.323MUnavailable4.63% · $3.094M100% · $66.812M
FY 2018 Q148.92% · $3.951MUnavailableUnavailableUnavailable51.08% · $4.125M100% · $8.076M
FY 2018 Q258.61% · $5.842MUnavailableUnavailableUnavailable41.39% · $4.125M100% · $9.967M
FY 2018 Q38.51% · $2.782MUnavailable0% · $0MUnavailable91.49% · $29.906M100% · $32.688M
FY 2018 Q49.2% · $3.449MUnavailable0% · $0MUnavailable90.8% · $34.032M100% · $37.481M
FY 2019 Q19.5% · $2.52MUnavailable0% · $0MUnavailable90.5% · $24M100% · $26.52M
FY 2019 Q25.79% · $3.47MUnavailable0% · $0MUnavailable94.21% · $56.438M100% · $59.908M
FY 2019 Q3100% · $6.162MUnavailable0% · $0MUnavailable0% · $0M100% · $6.162M
FY 2019 Q4100% · $5.76MUnavailable0% · $0MUnavailable0% · $0M100% · $5.76M
FY 2020 Q111.75% · $5.561MUnavailable88.25% · $41.776MUnavailable0% · $0M100% · $47.337M
FY 2020 Q250.74% · $9.324MUnavailable49.26% · $9.051MUnavailable0% · $0M100% · $18.375M
FY 2020 Q3100% · $8.669MUnavailable0% · $0MUnavailable0% · $0M100% · $8.669M
FY 2020 Q414.1% · $7.786MUnavailable85.9% · $47.447MUnavailable0% · $0M100% · $55.233M
FY 2021 Q1100% · $6.507MUnavailable0% · $0MUnavailableUnavailable100% · $6.507M
FY 2021 Q29.71% · $6.008MUnavailable90.29% · $55.877MUnavailableUnavailable100% · $61.885M
FY 2021 Q351.64% · $6.64MUnavailable48.36% · $6.219MUnavailableUnavailable100% · $12.859M
FY 2021 Q4100% · $9.116MUnavailable0% · $0MUnavailableUnavailable100% · $9.116M
FY 2022 Q12.13% · $9.257MUnavailable97.87% · $425.95MUnavailableUnavailable100% · $435.207M
FY 2022 Q22.9% · $11.2MUnavailable97.1% · $374.717MUnavailableUnavailable100% · $385.917M
FY 2022 Q3100% · $7.179MUnavailable0% · $0MUnavailableUnavailable100% · $7.179M
FY 2022 Q416.38% · $9.243MUnavailable83.62% · $47.182MUnavailableUnavailable100% · $56.425M
FY 2023 Q17.34% · $9.513MUnavailable92.66% · $120.146MUnavailableUnavailable100% · $129.659M
FY 2023 Q226.13% · $8.446MUnavailable73.87% · $23.874MUnavailableUnavailable100% · $32.32M
FY 2023 Q3100% · $8.703MUnavailable0% · $0MUnavailableUnavailable100% · $8.703M
FY 2023 Q4100% · $9.986MUnavailable0% · $0MUnavailableUnavailable100% · $9.986M
FY 2024 Q1100% · $5.497MUnavailable0% · $0MUnavailableUnavailable100% · $5.497M
FY 2024 Q2100% · $12.871MUnavailable0% · $0MUnavailableUnavailable100% · $12.871M
FY 2024 Q3100% · $10.537MUnavailable0% · $0MUnavailableUnavailable100% · $10.537M
FY 2024 Q44.31% · $7.643MUnavailable95.69% · $169.867MUnavailableUnavailable100% · $177.51M
FY 2025 Q12.62% · $9.994MUnavailable97.38% · $371.9MUnavailableUnavailable100% · $381.894M
FY 2025 Q21.12% · $6.113MUnavailable98.88% · $540.915MUnavailableUnavailable100% · $547.028M
FY 2025 Q370.08% · $10.713MUnavailable29.92% · $4.574MUnavailableUnavailable100% · $15.287M
FY 2025 Q4100% · $4.536MUnavailable0% · $0MUnavailableUnavailable100% · $4.536M
FY 2026 Q1100% · $6.814MUnavailable0% · $0MUnavailableUnavailable100% · $6.814M
FY 2026 Q27.5% · $23.911MUnavailable92.5% · $294.764MUnavailableUnavailable100% · $318.675M
Sep 30, 2016 through Jun 30, 2026

Operating cash flow

USD millions

$162.011M

Capital expenditures

USD millions

$23.911M

Free cash flow

USD millions

$138.1M

Stock-based compensation

USD millions

$4.348M

SBC / free cash flow

% · FCF before SBC deduction

3.15%

SBC / operating cash flow

%

2.68%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$4.25

Quarterly data

Medpace cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 2026162.0123.91138.14.353.15%2.68%—$4.25
FY 2026 Q1Mar 31, 2026151.796.81144.974.923.39%3.24%—$4.28
FY 2025 Q4Dec 31, 2025192.654.54188.125.622.99%2.92%——
FY 2025 Q3Sep 30, 2025246.2110.71235.56.322.68%2.57%—$3.86
FY 2025 Q2Jun 30, 2025148.536.11142.415.954.18%4.01%—$3.1
FY 2025 Q1Mar 31, 2025125.849.99115.8416.8914.58%13.42%—$3.67
FY 2024 Q4Dec 31, 2024190.677.64183.025.893.22%3.09%——
FY 2024 Q3Sep 30, 2024149.0810.54138.5411.738.46%7.87%—$3.01
FY 2024 Q2Jun 30, 2024116.412.87103.533.593.47%3.08%—$2.75
FY 2024 Q1Mar 31, 2024152.685.5147.184.312.93%2.82%—$3.2
FY 2023 Q4Dec 31, 2023156.49.99146.415.173.53%3.3%——
FY 2023 Q3Sep 30, 2023114.398.7105.685.014.74%4.38%—$2.22
FY 2023 Q2Jun 30, 202382.528.4574.074.916.62%5.95%—$1.93
FY 2023 Q1Mar 31, 202380.089.5170.565.447.71%6.79%—$2.27
FY 2022 Q4Dec 31, 2022136.689.24127.445.594.39%4.09%——
FY 2022 Q3Sep 30, 2022108.497.18101.315.795.72%5.34%—$2.05
FY 2022 Q2Jun 30, 202296.6211.285.425.656.62%5.85%—$1.46
FY 2022 Q1Mar 31, 202246.269.26374.3711.82%9.45%—$1.69
FY 2021 Q4Dec 31, 202170.899.1261.783.986.44%5.62%——
FY 2021 Q3Sep 30, 202172.356.6465.714.056.16%5.59%—$1.29
FY 2021 Q2Jun 30, 202162.766.0156.753.576.29%5.69%—$1.06
FY 2021 Q1Mar 31, 202157.326.5150.812.875.65%5.01%—$1.14
FY 2020 Q4Dec 31, 2020105.57.7997.712.963.03%2.81%——
FY 2020 Q3Sep 30, 202059.768.6751.092.765.41%4.62%—$1.09
FY 2020 Q2Jun 30, 202044.279.3234.942.627.49%5.91%—$0.64
FY 2020 Q1Mar 31, 202049.155.5643.595.4512.49%11.08%—$0.76
FY 2019 Q4Dec 31, 201956.945.7651.182.715.29%4.75%—$0.78
FY 2019 Q3Sep 30, 201964.296.1658.139.4716.28%14.72%—$0.63
FY 2019 Q2Jun 30, 201946.633.4743.165.3912.48%11.55%—$0.73
FY 2019 Q1Mar 31, 201934.012.5231.493.1810.11%9.36%—$0.51
FY 2018 Q4Dec 31, 201839.443.4535.992.115.87%5.36%—$0.61
FY 2018 Q3Sep 30, 201852.52.7849.721.432.88%2.73%—$0.52
FY 2018 Q2Jun 30, 201841.345.8435.51.494.19%3.6%—$0.45
FY 2018 Q1Mar 31, 201823.33.9519.351.477.58%6.3%—$0.4
FY 2017 Q4Dec 31, 201728.653.425.261.254.94%4.36%—$0.3
FY 2017 Q3Sep 30, 2017392.3136.690.982.67%2.52%—$0.25
FY 2017 Q2Jun 30, 201730.411.6528.761.24.17%3.95%—$0.23
FY 2017 Q1Mar 31, 2017-0.684.37-5.051.03———$0.2
FY 2016 Q4Dec 31, 201629.575.6923.881.265.26%4.25%—$0
FY 2016 Q3Sep 30, 201641.672.1539.524.2810.84%10.28%—$0.13
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · MEDP, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.